EntreMed, Aventis in prostate cancer study

EntreMed (ENMD) and Aventis Pharmaceuticals (Bridgewater, N.J.) will collaborate on a Phase II dose-finding study of Panzem 2-methoxyestradiol hormone in combination with Taxotere docetaxel, Aventis's...